Metformin use and lung cancer survival: a population-based study in Norway.
Suzan BrancherNathalie C StøerElisabete WeiderpassRonald A M DamhuisTom B JohannesenEdoardo BotteriTrond-Eirik StrandPublished in: British journal of cancer (2020)
Metformin use was associated with improved survival, especially LCSS in patients with regional stage SCC. Further prospective studies are required to clarify the role of metformin in LC treatment.